RxDoctor Payments Data

Melissa Perchellet, MD

Addiction Psychiatry · Kansas City, KSNPI 1851413397

Payments from drug & device makers

$1,294in general payments, 2019–2025

Across 76 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$316
  • Otsuka America Pharmaceutical, Inc.$134
  • Takeda Pharmaceuticals U.S.A., Inc.$122
  • Indivior Inc.$96
  • Alkermes, Inc.$86
  • Vanda Pharmaceuticals Inc.$70
  • plus $470 from 13 others

What the payments were for

  • Food & beverage$1,294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few addiction psychiatry providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$42,122
Medicare patients
101
Services billed
321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl29$43,436
CaplytaLumateperone Tosylate12$21,118
Ziprasidone Hcl47$6,720
Aripiprazole98$5,978
Lurasidone Hcl15$5,909
Divalproex Sodium ErDivalproex Sodium44$5,123
Carbamazepine ErCarbamazepine61$3,228
Duloxetine Hcl140$3,180
Divalproex Sodium63$2,700
Clozapine74$2,595
Clonazepam229$2,019
Quetiapine Fumarate130$1,994
Escitalopram Oxalate122$1,925
Venlafaxine Hcl ErVenlafaxine Hcl87$1,853
Mirtazapine89$1,523

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$316$43,43629 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$23$21,11812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few addiction psychiatry providers in Kansason file to place this against a meaningful peer group, so we don't.

Other addiction psychiatry in Kansas City

Where these figures come from

Is this you, or does something look wrong? →